Emgality, taken once a month, can help prevent migraine before it starts

Select Safety Information
Do not use Emgality if you are allergic to galcanezumab-gnlm or any of the ingredients in Emgality.
In two 6-month studies, people with 4-14 migraine days per month


*In a 3-month study, the number of people with 15 or more headache days per month who achieved ≥75% or 100% reduction in monthly migraine days did not differ from people taking placebo.
Learn how you can save on Emgality
Select Safety Information
Emgality may cause allergic reactions, such as itching, rash, hives, and trouble breathing. Allergic reactions can happen days after using Emgality. Call your healthcare provider or get emergency medical help right away if you have any of the following symptoms, which may be part of an allergic reaction:
- swelling of your face, mouth, tongue, or throat
- trouble breathing

Don't just react to migraine. Help prevent migraine by taking Emgality just once a month
Historically, many preventive migraine medicines were designed for other conditions. Emgality is a CGRP antibody migraine treatment that was specifically developed to bind to CGRP, a substance in the brain that may play a key role in migraine, and block its binding to the receptor.

CGRP = calcitonin gene-related peptide.
Interested in learning about a once-monthly preventive treatment like Emgality? Sign up for the latest updates from Emgality for migraine